Literature DB >> 8648343

Pretarsal injections of botulinum toxin improve blepharospasm in previously unresponsive patients.

A Albanese, A R Bentivoglio, C Colosimo, G Galardi, L Maderna, P Tonali.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8648343      PMCID： PMC1073960          DOI： 10.1136/jnnp.60.6.693-a

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  5 in total

Review 1.  Therapeutic uses of botulinum toxin.

Authors:  J Jankovic; M F Brin
Journal:  N Engl J Med       Date:  1991-04-25       Impact factor: 91.245

2.  Botulinum toxin as a treatment for blepharospasm, spasmodic torticollis and hemifacial spasm.

Authors:  A Albanese; C Colosimo; D Carretta; A Dickmann; A R Bentivoglio; P Tonali
Journal:  Eur Neurol       Date:  1992       Impact factor: 1.710

3.  Electromyographic features of levator palpebrae superioris and orbicularis oculi muscles in blepharospasm.

Authors:  M Aramideh; B W Ongerboer de Visser; P P Devriese; L J Bour; J D Speelman
Journal:  Brain       Date:  1994-02       Impact factor: 13.501

4.  Pretarsal application of botulinum toxin for treatment of blepharospasm.

Authors:  M Aramideh; B W Ongerboer de Visser; J W Brans; J H Koelman; J D Speelman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-09       Impact factor: 10.154

5.  Validity and reliability of a rating scale for the primary torsion dystonias.

Authors:  R E Burke; S Fahn; C D Marsden; S B Bressman; C Moskowitz; J Friedman
Journal:  Neurology       Date:  1985-01       Impact factor: 9.910
  5 in total
  8 in total

Review 1.  Blepharospasm 40 years later.

Authors:  Giovanni Defazio; Mark Hallett; Hyder A Jinnah; Antonella Conte; Alfredo Berardelli
Journal:  Mov Disord       Date:  2017-02-10       Impact factor: 10.338

2.  Use of Botulinum Toxin in Ophthalmology.

Authors:  Michael J Wan; Sara AlShaker; David G Hunter
Journal:  Handb Exp Pharmacol       Date:  2021

Review 3.  Guidelines for the therapeutic use of botulinum toxin in movement disorders. Italian Study Group for Movement Disorders, Italian Society of Neurology.

Authors:  A Berardelli; G Abbruzzese; L Bertolasi; G Cantarella; F Carella; A Currà; D De Grandis; G DeFazio; G Galardi; P Girlanda; P Livrea; N Modugno; A Priori; G Ruoppolo; L Vacca; M Manfredi
Journal:  Ital J Neurol Sci       Date:  1997-10

Review 4.  Treatment of Dystonia: Medications, Neurotoxins, Neuromodulation, and Rehabilitation.

Authors:  Ian O Bledsoe; Aaron C Viser; Marta San Luciano
Journal:  Neurotherapeutics       Date:  2020-10-23       Impact factor: 7.620

Review 5.  Botulinum toxin in the treatment of blepharospasm and hemifacial spasm.

Authors:  C Kenney; J Jankovic
Journal:  J Neural Transm (Vienna)       Date:  2007-06-11       Impact factor: 3.575

6.  The combined treatment with orbital and pretarsal botulinum toxin injections in the management of poorly responsive blepharospasm.

Authors:  Marcello Esposito; A Fasano; C Crisci; R Dubbioso; R Iodice; Lucio Santoro
Journal:  Neurol Sci       Date:  2013-08-15       Impact factor: 3.307

7.  Apraxia of Lid Opening in Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease-Frequency, Risk Factors and Response to Treatment.

Authors:  Syam Krishnan; Kuldeep Shetty; Divya Kalikavil Puthanveedu; Krishnakumar Kesavapisharady; Jissa Vinoda Thulaseedharan; Gangadhara Sarma; Asha Kishore
Journal:  Mov Disord Clin Pract       Date:  2021-04-12

Review 8.  Botulinum Toxin in Movement Disorders: An Update.

Authors:  Charenya Anandan; Joseph Jankovic
Journal:  Toxins (Basel)       Date:  2021-01-08       Impact factor: 4.546
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.